Famvir
(Famciclovir)ApprovedSmall molecule
NovartisFamciclovir is used to treat infections caused by herpes viruses, including cold sores, genital herpes, and shingles. It works by stopping the virus from multiplying in your body.[2] Famvir is currently approved and in use across 8 indications[4].[1]
Famvir is one of 108 small molecule programs targeting Viral Disease. It is currently in Approved.
8
Indications
20
Total Trials
1
Active Trials
107
Competitors
1
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Status by Indication[4][1]
Indication
Competition
Competitive Landscape
52 competitors in Viral Disease
#DrugCompanyPhaseTrials
1Famvir
NovartisApproved
Vistide
GileadApproved
Incivek
Vertex PharmaceuticalsApproved
Ziagen
GSKApproved
Sunlenca
GileadApproved
Emtriva
GileadApproved
Livtencity
TakedaApproved
Sovaldi
GileadApproved
Videx
Bristol-Myers SquibbApproved
Selzentry
GSKApproved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Genital Herpes4 trials
Fasting Conditions2 trials
Herpes Labialis2 trials
MCI2 trials
7 more indications
Herpes Zoster2 trials
Randomized1 trial
Treatment1 trial
Famvir for Treatment of Hearing in Unilateral Meniere's Disease
Terminated·—·Phase 3·NCT01526408·11 enrolled
Postherpetic Neuralgia1 trial
Effect of Early Use of Oxycodone During the Acute Phase of Herpes Zoster on Preventing Postherpetic Neuralgia
Unknown status·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·N/A·NCT03120962·140 enrolled
Varicella Zoster1 trial
Regulatory
FDA Approval Timeline[5]
Dec 11, 1995
FAMVIR
NDA NDA020363
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Famvir drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Famciclovir. EMBL-EBI & Wellcome Sanger Institute.
- [5]
- [6]